Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
Good Assays for Bad Immunogenicity
Avoid “Bad” Immunogenicity by Using Assays That Are More Sensitive and Can Adapt to Increasingly Complex and Specialized Drugs
For full access to this article login to GEN Select now.
Cell Viability & Responsiveness in Assays
Keeping Cells “Happy” and Healthy Helps Support Complex Multiplexed Assays
- Maintaining cell viability throughout the cell culture process is virtually a nonissue in current drug discovery efforts. But with the move toward multiplexed assays, and industry's desire for higher content without compromising throughput, it's worthwhile to think of cell viability along a spectrum and to consider cell health and ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.